Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 75-89
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.75
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.75
Figure 1 Schematic of basic domain structure of Bromodomain and extra-terminal protein family; BRD2, BRD3, BRD4, and BRDT.
Each Bromodomain and extra-terminal protein has two bromodomains (BD1 and BD2) and one extra-terminal domain. And BRD4 and BRDT specially contain a C-terminal motif. ET: Extra-terminal; BD: Bromodomain.
- Citation: Sun HY, Du ST, Li YY, Deng GT, Zeng FR. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 75-89
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/75.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.75